Literature DB >> 6114516

High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25.

P Brazeau, N Ling, F Esch, P Böhlen, R Benoit, R Guillemin.   

Abstract

We have isolated form extracts of ovine hypothalami two molecules characterized as somatostatin-28 and somatostatin-4-28 (referred to as somatostatin-25). They were reproduced by solid hase synthesis. In equimolar ratio and depending upon the experimental conditions, synthetic somatostatin-28 ans somatostatin-25 are 3-14 times more potent than somatostatin-14 to inhibit the basal in vitro secretion of growth hormone or as stimulated by prostaglandin (PGE2). In early studies in vivo, somatostatin-28 and somatostatin-25 are also more potent than somatostatin-14 in inhibiting the secretion of growth hormone acutely stimulated in the rat by injection of morphine; somatostatin-28 is also longer-acting than somatostatin-14. These results suggest that somatostatin-14, as originally isolated, is a biologically active fragment of a larger molecule of greater specific activity; it should be considered as another form of somatostatin with high biological activity present in some tissues and likely secreted y the tissues along with somatostatin-14 and possibly other somatostatin-peptides of diverse sizes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114516     DOI: 10.1016/0167-0115(81)90048-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  12 in total

1.  Tissue-specific distribution of cross-linked somatostatin receptor proteins in the rat.

Authors:  C B Srikant; K K Murthy; Y C Patel
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.

Authors:  E S McKeen; W Feniuk; A D Michel; E J Kidd; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

Review 3.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

4.  Phenotypic plasticity of Schwann cells and enteric glial cells in response to the microenvironment.

Authors:  C Dulac; N M Le Douarin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

5.  Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.

Authors:  H Cramer; D Schaudt; K Rissler; D Strubel; J M Warter; F Kuntzmann
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

6.  Effect of somatostatin and its analogs on histamine-stimulated cAMP production in isolated guinea pig gastric glands.

Authors:  S Nishihara; A Tanaka; K Yoshida; Y Imazono; T Misawa; A Funakoshi; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1985-12

7.  Plasma somatostatin 28 increases in response to feeding in man.

Authors:  K S Polonsky; S E Shoelson; H M Docherty
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

8.  Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro.

Authors:  P Brazeau; N Ling; P Böhlen; F Esch; S Y Ying; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Mediation by SRIF1 receptors of the contractile action of somatostatin in rat isolated distal colon; studies using some novel SRIF analogues.

Authors:  E S McKeen; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium.

Authors:  W Feniuk; J Dimech; P P Humphrey
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.